Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Doxorubicin and Docetaxel in Stage II-IIIB Breast Cancer
NCT00003953Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Feb 1999
- Primary completion
- Nov 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in breast cancer, sponsored by Case Comprehensive Cancer Center. Started Feb 1999; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003953.